Form4.ai tracks every SEC insider trade in real time. See every RAPP insider filing with a free account — no card.
See every RAPP insider filing — free account, no card.
Free accountRapport Therapeutics, Inc. (RAPP) has 17 SEC Form 4 insider filings on record in the last 90 days. That includes 7 insider purchases totalling $22.0M, and 9 sales totalling $6.9M. Most recent filing: Nov. 3, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Nov 3, 2026 SEC filing | Third Rock Ventures V, L.P. Director | Grant / award | $29,999,991 | — |
| Oct 30, 2026 SEC filing | HEALY JAMES Director | Bought | $20,359,080 | +15.3% 1D |
| Oct 23, 2026 SEC filing | Ceesay Abraham Chief Executive Officer | Sold | $64,448 | — |
Create a free account to see all 17 RAPP filings from the last 90 days. No card needed.
Create free accountWant RAPP insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.